4 December 2012
NANOCO GROUP PLC
("Nanoco" or the "Company")
Exercise of Options
Nanoco Group plc (AIM: NANO) announces that application has been made for the admission of 109,996 new ordinary shares in the Company of 10p each (the "New Ordinary Shares") to trading on AIM pursuant to the exercise of share options by employees.
It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing ordinary shares of the Company, will commence on 7 December 2012.
Following the issue of the New Ordinary Shares, the issued share capital will comprise of 208,987,913 ordinary shares.
For further information please contact:
Nanoco |
+ 44 (0) 161 603 7900 |
Michael Edelman, Chief Executive Officer |
|
Colin White, Chief Financial Officer |
|
|
|
Bank of America Merrill Lynch - Joint Broker |
+ 44 (0) 20 7995 7555 |
Matthew Blawat |
|
|
|
Canaccord Genuity - Nomad and Joint Broker |
+44 (0) 20 7523 8000 |
Simon Bridges |
|
Cameron Duncan |
|
|
|
Buchanan |
+ 44 (0) 20 7466 5000 |
Mark Court / Fiona Henson / Sophie Cowles |
|
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications including lighting, solar cells and biological imaging. Nanoco's quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass. Nanoco forms strategic partnerships with major end users across a range of applications.
Nanoco was founded in 2001 and is based in Manchester, UK. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.
For further information, please visit www.nanocogroupplc.com.